Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci | Zendy

F. W. Goldstein | Zendy; Anne Coutrot | Zendy; A Sieffer | Zendy; J. F. Acar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci

Author(s) -

F. W. Goldstein,

Anne Coutrot,

A Sieffer,

J. F. Acar

Publication year - 1990

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.34.5.899

Subject(s) - teicoplanin , microbiology and biotechnology , staphylococcus haemolyticus , vancomycin , agar dilution , coagulase , staphylococcus epidermidis , glycopeptide , micrococcaceae , agar dilution method , staphylococcus , biology , agar , staphylococcus aureus , antibacterial agent , bacteria , antibiotics , minimum inhibitory concentration , genetics

The activities of teicoplanin and vancomycin against 362 coagulase-negative staphylococci were determined by an agar dilution method. At the 4- and 32-micrograms/ml breakpoint levels of the National Committee for Clinical Laboratory Standards, 23.2% of the strains were intermediate and 1.7% were resistant to teicoplanin, in contrast to less than 0.3% intermediate to vancomycin. Resistant strains belonged to the species Staphylococcus epidermidis (74%) and S. haemolyticus (19%).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research